NN Investment Partners Holdings’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$14.5M Sell
244,421
-265
-0.1% -$16.9K 0.08% 217
2021
Q4
$17.8M Sell
244,686
-1,522
-0.6% -$105K 0.09% 199
2021
Q3
$17.2M Sell
246,208
-36,487
-13% -$2.56M 0.09% 178
2021
Q2
$19.5M Buy
282,695
+3,481
+1% +$232K 0.1% 169
2021
Q1
$18M Sell
279,214
-53,356
-16% -$3.44M 0.11% 166
2020
Q4
$19.4M Sell
332,570
-539,567
-62% -$32.6M 0.12% 158
2020
Q3
$55.1M Sell
872,137
-8,372
-1% -$581K 0.36% 56
2020
Q2
$67.7M Buy
880,509
+261,364
+42% +$20M 0.46% 47
2020
Q1
$46.3M Buy
619,145
+30,511
+5% +$2.11M 0.38% 58
2019
Q4
$38.2M Buy
588,634
+103,103
+21% +$6.71M 0.26% 84
2019
Q3
$30.8M Buy
485,531
+20,517
+4% +$1.34M 0.24% 93
2019
Q2
$31.4M Sell
465,014
-304,999
-40% -$20.1M 0.25% 96
2019
Q1
$50.1M Buy
770,013
+52,944
+7% +$3.52M 0.39% 61
2018
Q4
$44.9M Sell
717,069
-203,206
-22% -$14.2M 0.38% 66
2018
Q3
$71.1M Sell
920,275
-21,934
-2% -$1.66M 0.51% 47
2018
Q2
$66.7M Buy
942,209
+18,385
+2% +$1.3M 0.49% 48
2018
Q1
$69.6M Sell
923,824
-340,082
-27% -$27M 0.5% 48
2017
Q4
$90.5M Sell
1,263,906
-664,285
-34% -$50.4M 0.64% 41
2017
Q3
$156M Buy
1,928,191
+1,029,410
+115% +$78.7M 0.99% 22
2017
Q2
$63.6M Sell
898,781
-176,818
-16% -$11.8M 0.59% 46
2017
Q1
$73.1M Sell
1,075,599
-1,384,100
-56% -$97.3M 0.69% 36
2016
Q4
$176M Buy
2,459,699
+271,958
+12% +$20.2M 1.66% 8
2016
Q3
$173M Buy
2,187,741
+158,600
+8% +$12.9M 1.63% 9
2016
Q2
$169M Buy
2,029,141
+66,739
+3% +$5.92M 1.6% 7
2016
Q1
$180M Buy
+1,962,402
New +$177M 1.73% 6

Other funds holding GILD

NN Investment Partners Holdings's GILD Position: Q1 2022 in Review

NN Investment Partners Holdings reduced its Gilead Sciences (GILD) stake by 0.11% in Q1 2022, selling an estimated $16.9K and leaving 244,421 shares worth $14.5M. The position accounts for 0.08% of the portfolio, ranked #217.

NN Investment Partners Holdings first reported a position in GILD in Q1 2016 and has held it in 25 quarters since. The position peaked at $180M in Q1 2016. 1,601 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • NN Investment Partners Holdings held 244,421 shares of Gilead Sciences worth $14.5M as of Q1 2022.
  • NN Investment Partners Holdings sold 265 Gilead Sciences shares in Q1 2022, an estimated $16.9K.
  • Gilead Sciences made up 0.08% of NN Investment Partners Holdings's portfolio in Q1 2022, its #217 holding.
  • NN Investment Partners Holdings first reported a position in Gilead Sciences in Q1 2016 and has held it in 25 quarters since.
  • NN Investment Partners Holdings's Gilead Sciences position peaked at $180M in Q1 2016.
  • 1,601 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.